Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-121 Lotion PK Study in Acne
NCT02849860Phase 1Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Feb 2014
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tretinoin in acne vulgaris, sponsored by Valeant Pharmaceuticals. Primary endpoint: Evaluators Global Severity Score at Day 15. Started Feb 2014; status: completed.
02
Drugs
tretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02849860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02849860.